Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis

PURPOSE: Thromboembolism is a common adverse event in women treated with tamoxifen (TAM) for breast cancer. The risk in male breast cancer patients is poorly investigated. We aimed to examine the risk of thrombotic events after TAM in male breast cancer patients. PATIENTS AND METHODS: In this prospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Eggemann, Holm, Bernreiter, Anna-Lena, Reinisch, Mattea, Loibl, Sibylle, Taran, Florin-Andrei, Costa, Serban-Dan, Ignatov, Atanas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353985/
https://www.ncbi.nlm.nih.gov/pubmed/30655614
http://dx.doi.org/10.1038/s41416-018-0369-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353985/
https://www.ncbi.nlm.nih.gov/pubmed/30655614
http://dx.doi.org/10.1038/s41416-018-0369-2

Ejemplares similares